IndraLab

Statements

Hydroxychloroquine inhibits HbA1c. 6 / 6
| 6
reach
"In patients with type 2 diabetes on insulin therapy, hydroxychloroquine was also found to significantly reduce HbA1c compared to placebo at 6 months of follow-up [XREF_BIBR]."
27525682
reach
"However, hydroxychloroquine (HCQ), a broad anti-inflammatory agent has been shown to reduce HbA1c by 0.87%."
31801334
reach
"Another study found similar findings whereby HCQ lowers fasting and postprandial plasma glucose and HbA1c, but there was no effect on insulin levels [56]."
39273629
reach
"Even in another Indian trial hydroxychloroquine 400mg reduced HbA1c at tune of 1.3% whereas hydroxychloroquine 200mg reduced the same by o. 8% over 24week [XREF_BIBR]."
32594451
reach
"The results showed that HCQ decreased HbA1c and improved glucose tolerance without significant adverse effects during the first 6 months of treatment [59]."
36036333
reach
"In a trial comparing hydroxychloroquine to pioglitazone as add-on treatment to metformin plus sulfonylurea in insufficiently controlled T2D patients, hydroxychloroquine and pioglitazone similarly decr[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
30142486